Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions

D Handkiewicz-Junak, A Czarniecka… - Molecular and cellular …, 2010 - Elsevier
Gene expression profiling shows that, by gene signature, the difference between BRAF-
positive and BRAF-negative PTC is so distinct that BRAF-positive cancer may be regarded …

Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions

D Handkiewicz-Junak… - Molecular and …, 2010 - pubmed.ncbi.nlm.nih.gov
Gene expression profiling shows that, by gene signature, the difference between BRAF-
positive and BRAF-negative PTC is so distinct that BRAF-positive cancer may be regarded …

Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions.

D Handkiewicz-Junak, A Czarniecka… - Molecular and Cellular …, 2010 - europepmc.org
Gene expression profiling shows that, by gene signature, the difference between BRAF-
positive and BRAF-negative PTC is so distinct that BRAF-positive cancer may be regarded …

[引用][C] Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions

D Handkiewicz-Junak, A Czarniecka… - Molecular and Cellular …, 2010 - cir.nii.ac.jp
Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and
future directions | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions

D Handkiewicz-Junak, A Czarniecka… - Molecular and Cellular …, 2010 - infona.pl
Gene expression profiling shows that, by gene signature, the difference between BRAF-
positive and BRAF-negative PTC is so distinct that BRAF-positive cancer may be regarded …